This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Are Medical Stocks Lagging Encompass Health (EHC) This Year?
by Zacks Equity Research
Here is how Encompass Health (EHC) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
Are Options Traders Betting on a Big Move in ELAN Stock?
by Zacks Equity Research
Investors need to pay close attention to Elanco Animal Health Incorporated (ELAN) stock based on the movements in the options market lately.
What Makes Elanco Animal Health (ELAN) a New Buy Stock
by Zacks Equity Research
Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ELAN vs. USPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ELAN vs. USPH: Which Stock Is the Better Value Option?
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Encompass Health (EHC) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
Is the Options Market Predicting a Spike in Elanco Animal Health Stock?
by Zacks Equity Research
Investors need to pay close attention to ELAN stock based on the movements in the options market lately.
Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Elanco Animal Health (ELAN) delivered earnings and revenue surprises of 19.35% and 2.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Astrana Health, Inc. (ASTH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Astrana Health, Inc. (ASTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q1 Earnings Expected to Decline
by Zacks Equity Research
Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.